Integra Lifesciences Holdings (IART) Net Margin (2009 - 2026)
Integra Lifesciences Holdings (IART) posted Net Margin of 1.07% for Q2 2026, up 190.85% sequentially from 1.18% in Q1 2026, and up 11754.0% YoY from N/an in Q2 2025.
Integra Lifesciences Holdings (IART) Net Margin (2009 - 2026) Analysis & Trends
Integra Lifesciences Holdings has reported Net Margin for 17 years, with the latest figure at 1.07% in Q2 2026.
- Quarterly Net Margin rose 11754.0% year-over-year to 1.07% in Q2 2026, while the trailing twelve-month figure through Jun 2026 was 0.44% (up 3043.0% YoY) and the FY2025 annual result came in at 31.58%, down 3115.0% from the prior year.
- Net Margin rose to 1.07% in Q2 2026 per IART's latest filing, from 1.18% in the prior quarter.
- Over five years, Net Margin peaked at 13.3% in Q4 2022 and troughed at 116.47% in Q2 2025.
- A 5-year average of 3.52% and a median of 1.08% in 2023 frame the typical range for Net Margin.
- The sharpest annual moves came in 2025 and 2026: Net Margin tumbled 11351 bps in 2025, then soared 11754 bps in 2026.
- Over 5 years, Net Margin stood at 13.3% in 2022, then plunged by 62 bps to 5.0% in 2023, then slipped by 12 bps to 4.39% in 2024, then sank by 109 bps to 0.39% in 2025, then surged by 373 bps to 1.07% in 2026.
- According to Business Quant data, Net Margin over the past three periods registered 1.07%, 1.18%, and 0.39% for Q2 2026, Q1 2026, and Q4 2025 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 200.19 Bn | 194.59 Bn | 7.27 Bn | 7.37% |
| 2 | Stryker | 129.95 Bn | 126.47 Bn | 4.50 Bn | 19.37% |
| 3 | Medtronic | 120.06 Bn | 110.84 Bn | 6.41 Bn | 12.84% |
| 4 | Boston Scientific | 74.14 Bn | 73.60 Bn | 3.85 Bn | 16.67% |
| 5 | Edwards Lifesciences | 52.74 Bn | 48.49 Bn | 1.35 Bn | 13.87% |
| 6 | Dexcom | 34.60 Bn | 32.65 Bn | 830.00 Mn | 19.04% |
| 7 | GE HealthCare Technologies | 34.20 Bn | 32.10 Bn | 2.18 Bn | 10.84% |
| 8 | Koninklijke Philips | 26.46 Bn | 23.13 Bn | 4.55 Bn | 6.47% |
| 9 | Steris | 23.25 Bn | 22.77 Bn | 684.20 Mn | 13.47% |
| 10 | Integra Lifesciences Holdings | 1.32 Bn | 1.05 Bn | 219.74 Mn | 1.07% |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.07% |
| Mar 31, 2026 | -1.18% |
| Dec 31, 2025 | -0.39% |
| Sep 30, 2025 | -1.34% |
| Jun 30, 2025 | -116.47% |
| Mar 31, 2025 | -6.61% |
| Dec 31, 2024 | 4.39% |
| Sep 30, 2024 | -2.81% |
| Jun 30, 2024 | -2.97% |
| Mar 31, 2024 | -0.89% |
| Dec 31, 2023 | 5.00% |
| Sep 30, 2023 | 5.10% |
| Jun 30, 2023 | 1.10% |
| Mar 31, 2023 | 6.36% |
| Dec 31, 2022 | 13.30% |
| Sep 30, 2022 | 12.96% |
| Jun 30, 2022 | 11.26% |
| Mar 31, 2022 | 8.74% |
| Dec 31, 2021 | 11.19% |
| Sep 30, 2021 | 11.17% |